StockMacro
Menu

Universal Health Services

$179.43 +15% in 6 monthsMarket cap $10.3B

UHS on XNYS, Health Care, Universal Health Services, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 8.0% to $18.4B over 12 months but shares are down 20% in a year.

  • GoodInstitutional holders rose 8.4% to 630 in the latest quarter
  • GoodNet income rose 6.3% to $1.5B over 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Universal Health Services primarily offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the US, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.

Industry
Services-general medical & surgical hospitals, nec (Health Care)
Employees
101,500
Website
uhs.com
Listed
NYSE, US
Last results
27 Oct 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $4.7B, net income $308.7M.
Quarter to 31 Dec 2021: revenue $3.3B, net income $239.1MQuarter to 31 Dec 2021: revenue $3.3B, net income $239.1MQuarter to 31 Mar 2022: revenue $3.3B, net income $153.9MQuarter to 31 Mar 2022: revenue $3.3B, net income $153.9MQuarter to 30 Jun 2022: revenue $3.3B, net income $164.1MQuarter to 30 Jun 2022: revenue $3.3B, net income $164.1MQuarter to 30 Sep 2022: revenue $3.3B, net income $182.8MQuarter to 30 Sep 2022: revenue $3.3B, net income $182.8MQuarter to 31 Dec 2022: revenue $3.4B, net income $174.8MQuarter to 31 Dec 2022: revenue $3.4B, net income $174.8MQuarter to 31 Mar 2023: revenue $3.5B, net income $163.1MQuarter to 31 Mar 2023: revenue $3.5B, net income $163.1MQuarter to 30 Jun 2023: revenue $3.5B, net income $171.3MQuarter to 30 Jun 2023: revenue $3.5B, net income $171.3MQuarter to 30 Sep 2023: revenue $3.6B, net income $167.0MQuarter to 30 Sep 2023: revenue $3.6B, net income $167.0MQuarter to 31 Dec 2023: revenue $3.7B, net income $216.4MQuarter to 31 Dec 2023: revenue $3.7B, net income $216.4MQuarter to 31 Mar 2024: revenue $3.8B, net income $261.8MQuarter to 31 Mar 2024: revenue $3.8B, net income $261.8MQuarter to 30 Jun 2024: revenue $3.9B, net income $289.2MQuarter to 30 Jun 2024: revenue $3.9B, net income $289.2MQuarter to 30 Sep 2024: revenue $4.0B, net income $258.7MQuarter to 30 Sep 2024: revenue $4.0B, net income $258.7MQuarter to 31 Dec 2024: revenue $4.1B, net income $332.4MQuarter to 31 Dec 2024: revenue $4.1B, net income $332.4MQuarter to 31 Mar 2025: revenue $4.1B, net income $316.7MQuarter to 31 Mar 2025: revenue $4.1B, net income $316.7MQuarter to 30 Jun 2025: revenue $4.3B, net income $353.2MQuarter to 30 Jun 2025: revenue $4.3B, net income $353.2MQuarter to 30 Sep 2025: revenue $4.5B, net income $373.0MQuarter to 30 Sep 2025: revenue $4.5B, net income $373.0MQuarter to 31 Dec 2025: revenue $4.5B, net income $445.9MQuarter to 31 Dec 2025: revenue $4.5B, net income $445.9MQuarter to 31 Mar 2026: revenue $4.5B, net income $348.7MQuarter to 31 Mar 2026: revenue $4.5B, net income $348.7MQuarter to 30 Jun 2026: revenue $4.6B, net income $358.4MQuarter to 30 Jun 2026: revenue $4.6B, net income $358.4MQuarter to 30 Sep 2026: revenue $4.7B, net income $308.7MQuarter to 30 Sep 2026: revenue $4.7B, net income $308.7M
31 Dec 2021RevenueNet incometallest bar $4.7B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$4.7B$308.7M
30 Jun 2026$4.6B$358.4M
31 Mar 2026$4.5B$348.7M
31 Dec 2025$4.5B$445.9M
30 Sep 2025$4.5B$373.0M
30 Jun 2025$4.3B$353.2M
31 Mar 2025$4.1B$316.7M
31 Dec 2024$4.1B$332.4M
30 Sep 2024$4.0B$258.7M
30 Jun 2024$3.9B$289.2M
31 Mar 2024$3.8B$261.8M
31 Dec 2023$3.7B$216.4M
30 Sep 2023$3.6B$167.0M
30 Jun 2023$3.5B$171.3M
31 Mar 2023$3.5B$163.1M
31 Dec 2022$3.4B$174.8M
30 Sep 2022$3.3B$182.8M
30 Jun 2022$3.3B$164.1M
31 Mar 2022$3.3B$153.9M
31 Dec 2021$3.3B$239.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $18.4B $17.0B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +8.0% +4.0%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $1.5B $1.4B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $23.88 $21.03
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 10.8% 11.5% -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 8.0% 8.1% 5.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 19.8% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $1.1B $968.3M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $168.7M $112.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $5.7B $4.7B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $5.5B $4.6B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.75 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 7.1 7.1
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.56 0.75
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.87 1.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.4 2.2
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 0.45% 1.6%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Universal Health ServicesUHS (this company) $10.3B7.10.56+8.0%8.0%
Tenet Healthcare Corporation NewTHC $20.9B5.50.95+6.2%17.2%
Surgery PartnersSGRY $3.5Bloss1.0+2.2%-2.6%
Ardent HealthARDT $2.1B14.50.33+2.0%2.3%
HCA HealthcareHCA $99.3B14.71.3+5.8%8.6%
EnsignENSG $10.3B25.81.8+17%7.0%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.4%

630 13F filers vs 581

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

–

No 13F holdings or share count.

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

–

2.5M shares sold short (30 Oct 2026); no share count in the company's filings in our data

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.6

2.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.5%

2.6M shares sold short in the report before, 2.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

60%

60% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 66%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+5.3%

$4.7B vs $4.5B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-6.1%

$214.9M vs $228.9M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$60K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

51

51 articles in the last 7 days; its usual week has 6 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.5×

51 articles in the last 7 days; its usual week has 6.

Price $179.43 on 20 Nov 2026, -20% over 12 months (12-month range $141.17 to $244.18)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $128K in the last 12 months (the 12 months before: -$1.8M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $4.7B in the latest quarter, +5.3% on a year earlier.
Capital spending per quarter. Capital spending $214.9M in the latest quarter, -6.1% on a year earlier.
Institutional holders (13F filers). 630 13F filers reported holding it in the latest 13F quarter, +5.0% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.
Lobbying spend. Lobbying spend: $60K published in the last 12 months, -25% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
7 Jul 2026Lobbying filingnew lobbying registration (MR. KYLE MULROY)
16 Jun 2026Sharp changeShort interest spike: short interest spike, 3.0M vs usual 2.1M (2026-05-29); 1.4x the same period a year earlier
2 Jun 2026Sharp changeShort interest spike: short interest spike, 3.0M vs usual 2.1M (2026-05-15); 1.2x the same period a year earlier
27 May 2026Lobbying filinglobbying engagement terminated (WASHINGTON STRATEGIC CONSULTING)
21 May 20268-K and other filingsDirector or officer change
30 Mar 20268-K and other filingsDirector or officer change
31 Dec 20258-K and other filingsDirector or officer change
31 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Apr 2025Sharp changeShort interest spike: short interest spike, 2.7M vs usual 1.6M (2025-03-31); 1.8x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.5M (2025-03-14); 1.8x the same period a year earlier
20 Mar 20258-K and other filingsDirector or officer change
20 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 May 2024Sharp changeShort interest spike: short interest spike, 2.5M vs usual 1.7M (2024-05-15); 1.5x the same period a year earlier
25 Mar 20248-K and other filingsDirector or officer change
25 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Oct 2023Sharp changeFederal obligations jump: federal obligations jump, 7.8M vs usual 0 in the same month of earlier years (2023-09-01..2023-09-30)
3 Oct 2023Sharp changeFederal obligations jump: federal obligations jump, 5.8M vs usual 0 in the same month of earlier years (2023-08-01..2023-08-31)
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 71 vs usual 45.50 (2023-06-30); 1.4x the same period a year earlier
27 Jun 2023Sharp changeFederal obligations jump: federal obligations jump, 5.7M vs usual 0 in the same month of earlier years (2023-05-01..2023-05-31)
24 Mar 20238-K and other filingsDirector or officer change
17 Mar 20238-K and other filingsDirector or officer change
17 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Oct 20228-K and other filingsDirector or officer change
22 Sep 20228-K and other filingsDirector or officer change
22 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Jun 2022Sharp changeShort interest spike: short interest spike, 3.7M vs usual 2.1M (2022-06-15); 1.6x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 3.6M vs usual 2.1M (2022-05-31); 1.9x the same period a year earlier
28 Mar 20228-K and other filingsDirector or officer change
28 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$383K published
Month from 1 Mar 2023: -$298K published
Month from 1 May 2023: -$10.5M published
Month from 1 Jun 2023: -$113K published
Month from 1 Dec 2023: -$161K published
Month from 1 Mar 2024: -$9.3M published
Month from 1 May 2024: -$434K published
Month from 1 Jul 2024: -$4.3M published
Month from 1 Aug 2024: -$1.3M published
Month from 1 Dec 2024: -$309K published
Month from 1 Mar 2025: -$179K published
Month from 1 May 2025: -$210K published
Month from 1 Oct 2025: -$218K published
Month from 1 Nov 2025: -$852K published
Month from 1 Mar 2026: -$128K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 3 published
Revenue per quarter
Quarter ended 31 Dec 2021: $3.3B, +6.1% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $3.3B, +9.3% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $3.3B, +3.9% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $3.3B, +5.7% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $3.4B, +5.2% on a year earlier; public on 28 Feb 2023
Quarter ended 31 Mar 2023: $3.5B, +5.3% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $3.5B, +6.8% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $3.6B, +6.8% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $3.7B, +7.4% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $3.8B, +11% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $3.9B, +10% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $4.0B, +11% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $4.1B, +11% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $4.1B, +6.7% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $4.3B, +9.6% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $4.5B, +13% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $4.5B, +9.1% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $4.5B, +9.6% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $4.6B, +8.3% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $4.7B, +5.3% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $189.6M, +2.7% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $200.0M, -19% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $208.0M, -11% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $161.6M, -12% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $164.4M, -13% on a year earlier; public on 28 Feb 2023
Quarter ended 31 Mar 2023: $168.8M, -16% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $167.9M, -19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $200.0M, +24% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $206.4M, +26% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $208.5M, +24% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $241.4M, +44% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $247.9M, +24% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $245.9M, +19% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $239.0M, +15% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $266.0M, +10% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $228.9M, -7.7% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $281.2M, +14% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $217.2M, -9.1% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $227.6M, -14% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $214.9M, -6.1% on a year earlier; public on 7 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 411; public on 14 Feb 2022
31 Mar 2022 report: 436; public on 16 May 2022
30 Jun 2022 report: 409; public on 15 Aug 2022
30 Sep 2022 report: 388; public on 14 Nov 2022
31 Dec 2022 report: 390; public on 14 Feb 2023
31 Mar 2023 report: 385; public on 15 May 2023
30 Jun 2023 report: 420; public on 14 Aug 2023
30 Sep 2023 report: 405; public on 14 Nov 2023
31 Dec 2023 report: 436; public on 14 Feb 2024
31 Mar 2024 report: 474; public on 15 May 2024
30 Jun 2024 report: 503; public on 14 Aug 2024
30 Sep 2024 report: 582; public on 14 Nov 2024
31 Dec 2024 report: 579; public on 14 Feb 2025
31 Mar 2025 report: 592; public on 15 May 2025
30 Jun 2025 report: 595; public on 14 Aug 2025
30 Sep 2025 report: 600; public on 14 Nov 2025
31 Dec 2025 report: 656; public on 17 Feb 2026
31 Mar 2026 report: 638; public on 15 May 2026
30 Jun 2026 report: 581; public on 14 Aug 2026
30 Sep 2026 report: 630; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2022: -$722 published
Month from 1 Dec 2022: $3.0M published
Month from 1 Jan 2023: $1.4M published
Month from 1 Feb 2023: $1.5M published
Month from 1 Mar 2023: $2.9M published
Month from 1 Apr 2023: $4.4M published
Month from 1 May 2023: $3.7M published
Month from 1 Jun 2023: $5.9M published
Month from 1 Jul 2023: $2.1M published
Month from 1 Aug 2023: $3.8M published
Month from 1 Sep 2023: $5.8M published
Month from 1 Oct 2023: $7.8M published
Month from 1 Dec 2023: $323K published
Month from 1 Jan 2024: -$1.5M published
Month from 1 Oct 2024: $314K published
Month from 1 Mar 2025: $541K published
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Apr 2022: $20K published
Quarter from 1 Oct 2022: $20K published
Quarter from 1 Jan 2023: $20K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $20K published
Quarter from 1 Oct 2023: $20K published
Quarter from 1 Jan 2024: $20K published
Quarter from 1 Apr 2024: $20K published
Quarter from 1 Jul 2024: $20K published
Quarter from 1 Oct 2024: $20K published
Quarter from 1 Jan 2025: $20K published
Quarter from 1 Apr 2025: $20K published
Quarter from 1 Jul 2025: $20K published
Quarter from 1 Oct 2025: $20K published
Quarter from 1 Jan 2026: $20K published
Quarter from 1 Apr 2026: $20K published
Quarter from 1 Oct 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $128K (13 Mar 2026), 68% below its normal reading of $405K; higher than 13% of its own history.
  • Short interest spike: had 3.0M shares sold short in the 15 May 2026 report, 1.2× the same report last year Public on 28 May 2026.
  • Insider net buying (open market): Insiders sold a net $128K in the last 12 months (the 12 months before: -$1.8M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 52 insider trades

No trades in the last 90 days; the latest was filed 13 Mar 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Mar 2026Sussman Elliot J Md MbaDirectorSellafter exercising options674$190.06$128KForm 4
12 Nov 2025Warren J. NimetzDirectorSellafter exercising options3,817$223.31$852KForm 4
30 Oct 2025Sussman Elliot J Md MbaDirectorSellafter exercising options965$225.70$218KForm 4
15 May 2025Maria Ruderman SingerDirectorSell1,097$191.48$210KForm 4
11 Mar 2025Maria Ruderman SingerDirectorSellafter exercising options1,000$179.16$179KForm 4
12 Dec 2024Maria Ruderman SingerDirectorSellafter exercising options1,614$191.15$309KForm 4
15 Aug 2024Sussman Elliot J Md MbaDirectorSellafter exercising options1,722$218.08$376KForm 4
14 Aug 2024Warren J. NimetzDirectorSellafter exercising options3,444$217.64$750KForm 4

630 institutions reported shares at the end of Q3 2026; 111 opened a position, 71 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
First Eagle Investment Management, LLC4.6M$795.7M-4.5M-50%
BlackRock, Inc.3.9M$679.7M-159K-3.9%
Vanguard Capital Management LLC3.3M$574.4M-96K-2.8%
Dimensional Fund Advisors LP2.7M$467.0M+469K+21%
Pzena Investment Management LLC2.6M$454.3M+638K+32%
Vanguard Portfolio Management LLC2.3M$394.7M-187K-7.6%
FMR LLC (Fidelity)2.1M$372.6M+721K+51%
State Street Corp2.1M$362.1M-25K-1.2%
Geode Capital Management, LLC2.0M$347.0M+19K+1.0%
AQR Capital Management LLC1.9M$330.5M+1.4M+262%

Company events

All 42 company events

In 12 months: 4 major agreements, 3 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
21 Aug 2026Signed a major agreementSame filing: took on new debt8-K
13 Aug 2026Signed a major agreement8-K
21 Jul 2026Signed a major agreementSame filing: took on new debt8-K
21 May 2026Director or officer change8-K
24 Apr 2026Signed a major agreementSame filing: took on new debt8-K
30 Mar 2026Director or officer change8-K
31 Dec 2025Director or officer change8-K
20 Mar 2025Director or officer change8-K

Reported lobbying spend: $20K in Q3 2026, $20K in Q1 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2026NewMr. Kyle Mulroyfor Valley Health SystemMedicaid reform, physician financial arrangements, site neutral policiesHealth issuesFiling
31 Mar 2026EndedWashington Strategic Consultingfor Valley Health SystemMedicaid reform, physician financial arrangements, site neutral policiesHealth issuesFiling
31 Dec 2020EndedParker, Poe, Adams & Bernstein LLPfor Uhs Of Delaware IncNot statedFiling
7 Feb 2011NewParker, Poe, Adams & Bernstein LLPfor Uhs Of Delaware IncRepresentation re: appropriations, mental health, medicare and medicaidPharmacy, MED, ALC, Medicare/Medicaid, Science/technology, Budget, InsuranceFiling
1 Mar 2010NewHusch Blackwell, LLPfor Two Rivers Psychiatric Hospital, Inc.Educated members of the Missouri congressional delegation on the status of the Two Rivers Psychiatric Hospital Medicare certification. Worked with the Missouri delegation on a response to the efforts of the Centers for Medicare and Medicaid to decertify Two Rivers involvement in the Medicare prograHealth issuesFiling
1 Nov 2009EndedHusch Blackwell, LLPfor Two Rivers Psychiatric Hospital, Inc.Educated members of the Missouri congressional delegation on the status of the Two Rivers Psychiatric Hospital Medicare certification. Worked with the Missouri delegation on a response to the efforts of the Centers for Medicare and Medicaid to decertify Two Rivers involvement in the Medicare prograHealth issuesFiling
31 Dec 2007EndedDebrunner & Associatesfor Valley Health SystemNot statedFiling
9 Aug 2007NewWashington Strategic Consultingfor Valley Health SystemMedicare/Medicaid, BudgetFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Apr 2008. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Apr 2008COLUMBUS HOSPITALNEWARK, NJ8741 Jun 2008Notice

The 5 newest of 312 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 7 Jul 2026Lobbying record

    VALLEY HEALTH SYSTEM: new lobbying registration (MR. KYLE MULROY) (dated 1 Jul 2026)

  2. 10 Jun 2026Short interest and volume change

    had 3.0M shares sold short in the 29 May 2026 report, 1.4× the same report last year.

    Same report last year: 2.1M; its normal report is 2.1M.

    See the evidence
    This period
    3.0M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +4.4
    Same report last year
    2.1M
    History used
    3,073 days
    2025-05-30: 2.1M2025-06-13: 2.2M2025-06-30: 2.2M2025-07-15: 2.2M2025-07-31: 2.1M2025-08-15: 2.2M2025-08-29: 2.4M2025-09-15: 2.5M2025-09-30: 2.2M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.9M2025-11-28: 1.9M2025-12-15: 2.1M2025-12-31: 2.1M2026-01-15: 2.0M2026-01-30: 2.0M2026-02-13: 1.9M2026-02-27: 2.0M2026-03-13: 1.8M2026-03-31: 2.1M2026-04-15: 2.1M2026-04-30: 2.8M2026-05-15: 3.0M2026-05-29: 3.0M
    the 29 May 2026 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 28 May 2026Short interest and volume change

    had 3.0M shares sold short in the 15 May 2026 report, 1.2× the same report last year.

    Same report last year: 2.5M; its normal report is 2.1M.

    See the evidence
    This period
    3.0M (the 15 May 2026 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +4.5
    Same report last year
    2.5M
    History used
    3,059 days
    2025-05-15: 2.5M2025-05-30: 2.1M2025-06-13: 2.2M2025-06-30: 2.2M2025-07-15: 2.2M2025-07-31: 2.1M2025-08-15: 2.2M2025-08-29: 2.4M2025-09-15: 2.5M2025-09-30: 2.2M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.9M2025-11-28: 1.9M2025-12-15: 2.1M2025-12-31: 2.1M2026-01-15: 2.0M2026-01-30: 2.0M2026-02-13: 1.9M2026-02-27: 2.0M2026-03-13: 1.8M2026-03-31: 2.1M2026-04-15: 2.1M2026-04-30: 2.8M2026-05-15: 3.0M
    the 15 May 2026 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 27 May 2026Lobbying record

    VALLEY HEALTH SYSTEM: lobbying engagement terminated (WASHINGTON STRATEGIC CONSULTING) (dated 31 Mar 2026)

  5. 21 May 2026Filings record

    Director or officer change

  6. 30 Mar 2026Filings record

    Director or officer change

  7. 31 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 31 Dec 2025Filings record

    Director or officer change

  9. 10 Apr 2025Short interest and volume change

    had 2.7M shares sold short in the 31 Mar 2025 report, 1.8× the same report last year.

    Same report last year: 1.5M; its normal report is 1.6M.

    See the evidence
    This period
    2.7M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    192K
    How far from its usual level
    +3.8
    Same report last year
    1.5M
    History used
    2,649 days
    2024-03-28: 1.5M2024-04-15: 2.0M2024-04-30: 2.2M2024-05-15: 2.5M2024-05-31: 1.7M2024-06-14: 1.5M2024-06-28: 1.4M2024-07-15: 1.0M2024-07-31: 1.7M2024-08-15: 1.3M2024-08-30: 1.2M2024-09-13: 1.5M2024-09-30: 1.4M2024-10-15: 1.5M2024-10-31: 1.2M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.9M2024-12-31: 1.8M2025-01-15: 1.7M2025-01-31: 1.8M2025-02-14: 1.8M2025-02-28: 1.9M2025-03-14: 2.8M2025-03-31: 2.7M
    the 31 Mar 2025 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Mar 2025Short interest and volume change

    had 2.8M shares sold short in the 14 Mar 2025 report, 1.8× the same report last year.

    Same report last year: 1.5M; its normal report is 1.5M.

    See the evidence
    This period
    2.8M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    202K
    How far from its usual level
    +4.2
    Same report last year
    1.5M
    History used
    2,632 days
    2024-03-15: 1.5M2024-03-28: 1.5M2024-04-15: 2.0M2024-04-30: 2.2M2024-05-15: 2.5M2024-05-31: 1.7M2024-06-14: 1.5M2024-06-28: 1.4M2024-07-15: 1.0M2024-07-31: 1.7M2024-08-15: 1.3M2024-08-30: 1.2M2024-09-13: 1.5M2024-09-30: 1.4M2024-10-15: 1.5M2024-10-31: 1.2M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.9M2024-12-31: 1.8M2025-01-15: 1.7M2025-01-31: 1.8M2025-02-14: 1.8M2025-02-28: 1.9M2025-03-14: 2.8M
    the 14 Mar 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 20 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 20 Mar 2025Filings record

    Director or officer change

  13. 25 May 2024Short interest and volume change

    had 2.5M shares sold short in the 15 May 2024 report, 1.5× the same report last year.

    Same report last year: 1.7M; its normal report is 1.7M.

    See the evidence
    This period
    2.5M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    141K
    How far from its usual level
    +4.0
    Same report last year
    1.7M
    History used
    2,329 days
    2023-05-15: 1.7M2023-05-31: 2.1M2023-06-15: 1.9M2023-06-30: 2.0M2023-07-14: 1.9M2023-07-31: 1.7M2023-08-15: 1.7M2023-08-31: 1.8M2023-09-15: 1.8M2023-09-29: 1.8M2023-10-13: 1.6M2023-10-31: 1.6M2023-11-15: 1.7M2023-11-30: 1.6M2023-12-15: 1.5M2023-12-29: 1.7M2024-01-12: 1.5M2024-01-31: 1.6M2024-02-15: 1.5M2024-02-29: 1.4M2024-03-15: 1.5M2024-03-28: 1.5M2024-04-15: 2.0M2024-04-30: 2.2M2024-05-15: 2.5M
    the 15 May 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 25 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 25 Mar 2024Filings record

    Director or officer change

  16. 20 Dec 2023Insiders record

    Chen-Langenmayr Nina (director) bought 250 shares of UHS ($34,182) (dated 19 Dec 2023)

  17. 23 Oct 2023Government contracts change

    booked $7.8M in federal contract and grant obligations in September 2023, against none in the same month last year.

    See the evidence
    This period
    $7.8M (September 2023)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +7.8
    Same month last year
    $0
    History used
    2,201 days
    2018-09-01: $02019-09-01: $02020-09-01: $02021-09-01: $227K2022-09-01: $02023-09-01: $7.8M
    September 20235 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  18. 30 Sep 2023Government contracts change

    booked $5.8M in federal contract and grant obligations in August 2023, against none in the same month last year.

    See the evidence
    This period
    $5.8M (August 2023)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +5.8
    Same month last year
    $0
    History used
    2,171 days
    2018-08-01: $02019-08-01: $02020-08-01: $02021-08-01: $02022-08-01: $02023-08-01: $5.8M
    August 20235 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  19. 14 Aug 2023Institutional holdings change

    saw 71 13F filers open a new position in the quarter ended 30 Jun 2023, 1.4× the same quarter last year.

    Same quarter last year: 52; its normal quarter is 45.5.

    See the evidence
    This period
    71 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    45.5
    Typical spread (median absolute deviation)
    4.5
    How far from its usual level
    +3.8
    Same quarter last year
    52
    History used
    3,560 days
    2021-06-30: 482021-09-30: 402021-12-31: 412022-03-31: 502022-06-30: 522022-09-30: 412022-12-31: 672023-03-31: 432023-06-30: 71
    the quarter ended 30 Jun 20238 earlier quartersnormal: 45.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  20. 26 Jun 2023Government contracts change

    booked $5.7M in federal contract and grant obligations in May 2023, against none in the same month last year.

    See the evidence
    This period
    $5.7M (May 2023)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +5.7
    Same month last year
    $0
    History used
    2,079 days
    2018-05-01: $02019-05-01: $02020-05-01: $02021-05-01: $02022-05-01: $02023-05-01: $5.7M
    May 20235 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  21. 24 Mar 2023Filings record

    Director or officer change

  22. 17 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 17 Mar 2023Filings record

    Director or officer change

  24. 25 Oct 2022Filings record

    Director or officer change

  25. 22 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 22 Sep 2022Filings record

    Director or officer change

  27. 28 Jun 2022Short interest and volume change

    had 3.7M shares sold short in the 15 Jun 2022 report, 1.6× the same report last year.

    Same report last year: 2.3M; its normal report is 2.1M.

    See the evidence
    This period
    3.7M (the 15 Jun 2022 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +4.6
    Same report last year
    2.3M
    History used
    1,629 days
    2021-05-28: 1.9M2021-06-15: 2.3M2021-06-30: 2.2M2021-07-15: 2.0M2021-07-30: 2.1M2021-08-13: 1.4M2021-08-31: 1.7M2021-09-15: 1.9M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.5M2021-11-15: 1.7M2021-11-30: 2.1M2021-12-15: 2.1M2022-01-14: 2.1M2022-01-31: 2.6M2022-02-15: 2.5M2022-02-28: 2.7M2022-03-15: 2.2M2022-03-31: 2.2M2022-04-14: 2.3M2022-04-29: 2.4M2022-05-13: 2.7M2022-05-31: 3.6M2022-06-15: 3.7M
    the 15 Jun 2022 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Jun 2022Short interest and volume change

    had 3.6M shares sold short in the 31 May 2022 report, 1.9× the same report last year.

    Same report last year: 1.9M; its normal report is 2.1M.

    See the evidence
    This period
    3.6M (the 31 May 2022 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +4.3
    Same report last year
    1.9M
    History used
    1,614 days
    2021-05-14: 2.4M2021-05-28: 1.9M2021-06-15: 2.3M2021-06-30: 2.2M2021-07-15: 2.0M2021-07-30: 2.1M2021-08-13: 1.4M2021-08-31: 1.7M2021-09-15: 1.9M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.5M2021-11-15: 1.7M2021-11-30: 2.1M2021-12-15: 2.1M2022-01-14: 2.1M2022-01-31: 2.6M2022-02-15: 2.5M2022-02-28: 2.7M2022-03-15: 2.2M2022-03-31: 2.2M2022-04-14: 2.3M2022-04-29: 2.4M2022-05-13: 2.7M2022-05-31: 3.6M
    the 31 May 2022 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 28 Mar 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 28 Mar 2022Filings record

    Director or officer change

  31. 13 Sep 2021Filings record

    A major agreement ended

  32. 26 Jun 2021Short interest and volume change

    had 2.3M shares sold short in the 15 Jun 2021 report, 1.4× the same report last year.

    Same report last year: 1.6M; its normal report is 1.4M.

    See the evidence
    This period
    2.3M (the 15 Jun 2021 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    149K
    How far from its usual level
    +4.2
    Same report last year
    1.6M
    History used
    1,264 days
    2020-06-15: 1.6M2020-06-30: 1.1M2020-07-15: 1.5M2020-07-31: 1.4M2020-08-14: 1.6M2020-08-31: 1.3M2020-09-15: 1.4M2020-09-30: 1.4M2020-10-15: 1.3M2020-10-30: 1.3M2020-11-13: 1.3M2020-11-30: 1.3M2020-12-15: 1.4M2020-12-31: 1.1M2021-01-15: 1.8M2021-01-29: 1.3M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.1M2021-03-31: 1.5M2021-04-15: 1.7M2021-04-30: 2.2M2021-05-14: 2.4M2021-05-28: 1.9M2021-06-15: 2.3M
    the 15 Jun 2021 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 26 May 2021Short interest and volume change

    had 2.4M shares sold short in the 14 May 2021 report, 1.1× the same report last year.

    Same report last year: 2.2M; its normal report is 1.4M.

    See the evidence
    This period
    2.4M (the 14 May 2021 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    149K
    How far from its usual level
    +4.4
    Same report last year
    2.2M
    History used
    1,232 days
    2020-05-15: 2.2M2020-05-29: 1.9M2020-06-15: 1.6M2020-06-30: 1.1M2020-07-15: 1.5M2020-07-31: 1.4M2020-08-14: 1.6M2020-08-31: 1.3M2020-09-15: 1.4M2020-09-30: 1.4M2020-10-15: 1.3M2020-10-30: 1.3M2020-11-13: 1.3M2020-11-30: 1.3M2020-12-15: 1.4M2020-12-31: 1.1M2021-01-15: 1.8M2021-01-29: 1.3M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.1M2021-03-31: 1.5M2021-04-15: 1.7M2021-04-30: 2.2M2021-05-14: 2.4M
    the 14 May 2021 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 12 May 2021Short interest and volume change

    had 2.2M shares sold short in the 30 Apr 2021 report, 1.1× the same report last year.

    Same report last year: 2.0M; its normal report is 1.4M.

    See the evidence
    This period
    2.2M (the 30 Apr 2021 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    149K
    How far from its usual level
    +3.8
    Same report last year
    2.0M
    History used
    1,218 days
    2020-04-30: 2.0M2020-05-15: 2.2M2020-05-29: 1.9M2020-06-15: 1.6M2020-06-30: 1.1M2020-07-15: 1.5M2020-07-31: 1.4M2020-08-14: 1.6M2020-08-31: 1.3M2020-09-15: 1.4M2020-09-30: 1.4M2020-10-15: 1.3M2020-10-30: 1.3M2020-11-13: 1.3M2020-11-30: 1.3M2020-12-15: 1.4M2020-12-31: 1.1M2021-01-15: 1.8M2021-01-29: 1.3M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.1M2021-03-31: 1.5M2021-04-15: 1.7M2021-04-30: 2.2M
    the 30 Apr 2021 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 19 Mar 2021Filings record

    Director or officer change

  36. 19 Mar 2021Filings record

    A major agreement ended

  37. 12 Jan 2021Lobbying record

    UHS OF DELAWARE INC: lobbying engagement terminated (PARKER, POE, ADAMS & BERNSTEIN LLP) (dated 31 Dec 2020)

  38. 28 Dec 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 28 Dec 2020Filings record

    Director or officer change

  40. 6 Oct 2020Attention change

    drew 5,554 Wikipedia page views in the week of 28 Sep 2020, 8.1× the same week last year.

    Same week last year: 682; its normal week is 536.

    See the evidence
    This period
    5,554 (the week of 28 Sep 2020)
    Normal week (median of 26 earlier)
    536
    Typical spread (median absolute deviation)
    96
    How far from its usual level
    +25.1
    Same week last year
    682
    History used
    642 days
    2020-03-30: 2,3172020-04-06: 1,6202020-04-13: 1,0192020-04-20: 9252020-04-27: 1,3312020-05-04: 9502020-05-11: 1,7422020-05-18: 5092020-05-25: 9382020-06-01: 6092020-06-08: 4782020-06-15: 4992020-06-22: 4382020-06-29: 3662020-07-06: 4742020-07-13: 5372020-07-20: 5062020-07-27: 5722020-08-03: 4312020-08-10: 4032020-08-17: 4992020-08-24: 4862020-08-31: 4942020-09-07: 5352020-09-14: 6302020-09-21: 7362020-09-28: 5,554
    the week of 28 Sep 202026 earlier weeksnormal: 536

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

Showing the newest 40 of 70 entries; narrow the window or the kind of data to see older ones.

Not listed: 168 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000352915
Ticker
UHS
Domain
uhs.com
Employer name
Aiken Professional Association, LLC, COLUMBUS HOSPITAL, Psychiatric Solutions, LLC, River Oaks, Inc. d/b/a River Oaks Hospital and 4 more (8 unverified)
Fein
20-5093162, 27-3493136, 52-1357729, 61-1850432 and 2 more (6 unverified)
Hq location
PA|KING OF PRUSSIA|19406 (1 unverified)
Lobbying client
two rivers psychiatric hospital, uhs of delaware, valley health system
Name
1001 Medical Park Drive LLC, 2012 W. University Properties, LLC, 2026 W. University Properties, LLC, ABS LINCS KY, LLC and 892 more
Uei
DDZ8GKV951M4
Wikidata
Q7893967
Wikipedia
Universal Health Services
  • DOL H-1B labor condition applications and PERM certifications24 data points19 Jan 2026 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)13 records, 255 data points10 Apr 2002 to 30 Sep 2026
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)145 records25 Feb 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)768 data points31 Dec 2007 to 30 Sep 2026
  • SEC Form 4 insider transactions52 records, 156 data points9 Mar 2016 to 13 Mar 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards316 data points20 Sep 2017 to 21 Feb 2025
  • WARN layoff notices (state labor agencies)1 record, 3 data points31 Mar 2008 to 1 Apr 2008
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026